COVID-19: Hong Kong suspends use of Pfizer-BioNTech vaccine after defective batch

COVID-19: Hong Kong suspends use of Pfizer-BioNTech vaccine after defective batch

Hong Kong and Macau have suspended the use of the Pfizer-BioNTech COVID-19 vaccine, after a batch was found with packaging defects. Health officials have stressed there are no safety concerns for those who have already received their first dose.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia